GKIM
GW&K Investment Management Portfolio holdings
AUM
$11.2B
1-Year Return
17.28%
This Quarter Return
+14.11%
1 Year Return
+17.28%
3 Year Return
+73.9%
5 Year Return
+156.73%
10 Year Return
+412.58%
AUM
$10.7B
AUM Growth
+$771M
(+7.7%)
Cap. Flow
-$392M
Cap. Flow
% of AUM
-3.66%
Top 10 Holdings %
Top 10 Hldgs %
11.77%
Holding
965
New
39
Increased
358
Reduced
400
Closed
21
Top Buys
| 1 |
Procore
PCOR
|
$52.1M |
| 2 |
Tandem Diabetes Care
TNDM
|
$36.3M |
| 3 |
iShares Russell 2000 ETF
IWM
|
$31M |
| 4 |
Intapp
INTA
|
$26.9M |
| 5 |
Tri Pointe Homes
TPH
|
$24.4M |
Top Sells
| 1 |
Brookfield Infrastructure
BIPC
|
$37.5M |
| 2 |
Manhattan Associates
MANH
|
$35.5M |
| 3 |
Molina Healthcare
MOH
|
$24.6M |
| 4 |
INN
Summit Hotel Properties
INN
|
$22.5M |
| 5 |
Avantor
AVTR
|
$20.3M |
Sector Composition
| 1 | Industrials | 19.36% |
| 2 | Technology | 17.97% |
| 3 | Healthcare | 15.88% |
| 4 | Financials | 12.7% |
| 5 | Consumer Discretionary | 12.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
ICU Medical
ICUI
$3.24B
| $16.2M | 0.15% |
162,224
-16,415
| -9% | -$1.64M |
|
202
Wells Fargo
WFC
$253B
| $15.6M | 0.15% |
317,871
-8,069
| -2% | -$397K |
|
203
Thermo Fisher Scientific
TMO
$186B
| $15.6M | 0.15% |
29,443
+29,280
| +17,963% | +$15.5M |
|
204
Revolve Group
RVLV
$1.7B
| $15.4M | 0.14% |
927,100
-71,096
| -7% | -$1.18M |
|
205
Power Integrations
POWI
$2.52B
| $15.3M | 0.14% |
186,490
-35,518
| -16% | -$2.92M |
|
206
Legacy Housing
LEGH
$670M
| $15.1M | 0.14% |
598,893
-26,939
| -4% | -$679K |
|
207
Permian Resources
PR
$9.75B
| $15M | 0.14% |
+1,103,373
| New | +$15M |
|
208
TriNet
TNET
$3.43B
| $14.9M | 0.14% |
125,161
-5,700
| -4% | -$678K |
|
209
Rush Enterprises Class A
RUSHA
$4.53B
| $14.9M | 0.14% |
295,269
-13,050
| -4% | -$656K |
|
210
Ultragenyx Pharmaceutical
RARE
$3.07B
| $14.7M | 0.14% |
307,529
-3,386
| -1% | -$162K |
|
211
Saia
SAIA
$8.34B
| $14.2M | 0.13% |
32,330
+4,222
| +15% | +$1.85M |
|
212
TD Synnex
SNX
$12.3B
| $14.2M | 0.13% |
131,561
-5,950
| -4% | -$640K |
|
213
Idexx Laboratories
IDXX
$51.4B
| $14.1M | 0.13% |
25,464
-1,487
| -6% | -$825K |
|
214
BioCryst Pharmaceuticals
BCRX
$1.74B
| $14M | 0.13% |
2,337,683
-233,180
| -9% | -$1.4M |
|
215
First Mid Bancshares
FMBH
$963M
| $13.9M | 0.13% |
400,924
-18,660
| -4% | -$647K |
|
216
Kyndryl
KD
$7.57B
| $13.9M | 0.13% |
667,282
-28,015
| -4% | -$582K |
|
217
Fair Isaac
FICO
$36.8B
| $13.8M | 0.13% |
11,874
-12,141
| -51% | -$14.1M |
|
218
First Watch Restaurant Group
FWRG
$1.13B
| $13.7M | 0.13% |
681,888
-29,933
| -4% | -$602K |
|
219
Ducommun
DCO
$1.35B
| $13.7M | 0.13% |
+263,132
| New | +$13.7M |
|
220
CACI
CACI
$10.4B
| $13.7M | 0.13% |
42,241
-442
| -1% | -$143K |
|
221
Vita Coco
COCO
$2.19B
| $13.4M | 0.12% |
+520,800
| New | +$13.4M |
|
222
Barrett Business Services
BBSI
$1.24B
| $13.3M | 0.12% |
460,600
-21,200
| -4% | -$614K |
|
223
Park Aerospace
PKE
$380M
| $13.2M | 0.12% |
899,448
-41,654
| -4% | -$612K |
|
224
Charles River Laboratories
CRL
$8.07B
| $13.1M | 0.12% |
55,510
+9,782
| +21% | +$2.31M |
|
225
Allegiant Air
ALGT
$1.18B
| $13.1M | 0.12% |
158,138
-16,085
| -9% | -$1.33M |
|